Personalized strategies for the diagnosis and treatment of acute myeloid leukemia in patients of different ages in the context of a global infectious threat
Вестник Российской академии наук / Herald of the Russian Academy of Sciences · 2025
DOI: 10.7868/s3034520025030046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Вестник Российской академии наук / Herald of the Russian Academy of Sciences, 2025. Verfasst von A. V. Vinogradov.
Abstract (Originalsprache)
As part of the implementation of the national project “Fight against oncological diseases”, modern anti-tumor drugs of targeted action are being actively introduced into the healthcare system of the Russian Federation. The use of FMS-like tyrosine kinase 3 (FLT3) inhibitors in programmatic polychemotherapy of acute myeloid leukemias, based on genetic stratification, proved effective despite the epidemic risks caused by the pandemic of the COVID-19. In the context of the structural restructuring of healthcare due to the global infectious threat, the research data is discussed from the point of view of the transition to personalized medical services, which are provided at the expense of compulsory medical insurance.
Zitieren
APA
Vinogradov, A. V. (2025). Personalized strategies for the diagnosis and treatment of acute myeloid leukemia in patients of different ages in the context of a global infectious threat. Вестник Российской академии наук / Herald of the Russian Academy of Sciences. https://doi.org/10.7868/s3034520025030046
Vancouver
Vinogradov AV. Personalized strategies for the diagnosis and treatment of acute myeloid leukemia in patients of different ages in the context of a global infectious threat. Вестник Российской академии наук / Herald of the Russian Academy of Sciences. 2025. doi:10.7868/s3034520025030046
BibTeX
@article{Vinogradov2025,
author = {Vinogradov, A. V.},
title = {Personalized strategies for the diagnosis and treatment of acute myeloid leukemia in patients of different ages in the context of a global infectious threat},
journal = {Вестник Российской академии наук / Herald of the Russian Academy of Sciences},
year = {2025},
doi = {10.7868/s3034520025030046}
}
EUVIMED